Innoblative Designs

Innoblative Designs, Inc. is a medical device company founded in 2014 by Tyler Wanke.

The company is focused on developing and commercializing a novel technology for the treatment of early-stage breast cancer. Its main product is the SIRA™ RFA Electrosurgical Device, a single-use, disposable applicator that works in conjunction with a radiofrequency electrosurgical generator. This device is designed to ablate, or destroy, the surgical margins after the excision of a tumor, a critical step in preventing cancer recurrence.

The SIRA™ device has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), a status that expedites the development and review of medical devices that provide for more effective treatment of life-threatening or irreversibly debilitating diseases. The company serves the surgical oncology market, with a particular focus on breast cancer surgery. Its business model revolves around the sale of its disposable SIRA™ device to hospitals and surgical centers.

Keywords: medical devices, surgical oncology, breast cancer, radiofrequency ablation, electrosurgical device, surgical margins, soft tissue diseases, cancer treatment, disposable medical equipment, FDA approved